Published in Cell Immunol on September 15, 1980
Differentiation of T cell lymphokine gene expression: the in vitro acquisition of T cell memory. J Exp Med (1991) 2.78
Decreased production of interferon-gamma by human neonatal cells. Intrinsic and regulatory deficiencies. J Clin Invest (1986) 2.05
Cellular and molecular mechanisms for reduced interleukin 4 and interferon-gamma production by neonatal T cells. J Clin Invest (1991) 1.64
Activation of neonatal and adult human macrophages by alpha, beta, and gamma interferons. Infect Immun (1985) 1.20
Group B streptococcus-induced nitric oxide production in murine macrophages is CR3 (CD11b/CD18) dependent. Infect Immun (1994) 1.16
Analysis of T helper and antigen-presenting cell functions in cord blood and peripheral blood leukocytes from healthy children of different ages. J Clin Invest (1993) 1.15
Infection and interferon production in systemic juvenile chronic arthritis: a prospective study. Ann Rheum Dis (1984) 1.07
Dissociated production of interleukin-2 and immune (gamma) interferon by phytohaemagglutinin stimulated lymphocytes in healthy infants. Clin Exp Immunol (1985) 1.06
Cellular defenses against Toxoplasma gondii in newborns. J Clin Invest (1984) 1.05
Down-regulation of Th1 responses in human neonates. Clin Exp Immunol (2002) 1.03
Human recombinant interferon gamma enhances neonatal polymorphonuclear leukocyte activation and movement, and increases free intracellular calcium. J Exp Med (1991) 1.02
The migration of T cells in response to influenza virus is altered in neonatal mice. J Immunol (2010) 0.98
Cytokine receptor signalling in neonatal macrophages: defective STAT-1 phosphorylation in response to stimulation with IFN-gamma. Clin Exp Immunol (2001) 0.94
Interferon system in patients with systemic juvenile chronic arthritis: in vivo and in vitro studies. Clin Exp Immunol (1983) 0.93
Cord blood B cells are mature in their capacity to switch to IgE-producing cells in response to interleukin-4 in vitro. Clin Exp Immunol (1990) 0.93
Lymphokine production by human milk lymphocytes. Infect Immun (1981) 0.92
Susceptibility to acute mouse adenovirus type 1 respiratory infection and establishment of protective immunity in neonatal mice. J Virol (2012) 0.88
Reduced primary antigen-specific T-cell precursor frequencies in neonates is associated with deficient interleukin-2 production. Immunology (1996) 0.88
Effect of passive immunization or maternally transferred immunity on the antibody response to a genetic vaccine to rabies virus. J Virol (1998) 0.87
Natural killer cell function of human neonatal lymphocytes. Clin Exp Immunol (1982) 0.84
Production of interleukin-1 by mononuclear cells of newborns and their mothers. Clin Exp Immunol (1987) 0.84
Strong prostaglandin associated suppression of the proliferation of human maternal lymphocytes by neonatal lymphocytes linked to T versus T cell interactions and differential PGE2 sensitivity. Clin Exp Immunol (1985) 0.83
Adaptive and innate immune responsiveness to Borrelia burgdorferi sensu lato in exposed asymptomatic children and children with previous clinical Lyme borreliosis. Clin Dev Immunol (2011) 0.81
Presence of gamma interferon in human acute and congenital toxoplasmosis. J Clin Microbiol (1990) 0.80
Effect of IL-4 and interferon-gamma (IFN-gamma) on IL-3- and IL-5-induced eosinophil differentiation from human cord blood mononuclear cells. Clin Exp Immunol (1995) 0.80
Immune-specific gamma interferon production correlates with lymphocyte blastogenesis. J Clin Microbiol (1986) 0.80
Comparison of cytotoxic properties of neonatal and adult neutrophils and monocytes and enhancement by cytokines. Clin Diagn Lab Immunol (1994) 0.79
Naive human T cells can be a source of IL-4 during primary immune responses. Clin Exp Immunol (1999) 0.78
IL-1 beta and IL-3-like activity in preterm infants. Clin Exp Immunol (1993) 0.76
A longitudinal study of gamma-interferon production by peripheral blood mononuclear cells from breast- and bottle-fed infants. Clin Exp Immunol (1986) 0.75
Biosynthetic human interferon treatment of herpetic keratitis. Trans Am Ophthalmol Soc (1983) 0.75
IFN-γ Blocks Development of an Asthma Phenotype in Rhinovirus-infected Baby Mice by Inhibiting ILC2s. Am J Respir Cell Mol Biol (2016) 0.75
Effect of gamma interferon on expression of Fc gamma receptors in monocytes of newborn infants and adults. Clin Diagn Lab Immunol (1996) 0.75
Direct TLR-2 Costimulation Unmasks the Proinflammatory Potential of Neonatal CD4+ T Cells. J Immunol (2016) 0.75
CCR5 expression and beta-chemokine production during placental neonatal monocyte differentiation. Pediatr Res (2003) 0.75
Latent tuberculosis in a newborn: diagnostic challenges. Eur J Pediatr (2010) 0.75
Serum levels of immune globulins in health and disease: a survey. Pediatrics (1966) 6.10
Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol (2000) 4.70
Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load. JAMA (1996) 4.33
Severe candidal infections: clinical perspective, immune defense mechanisms, and current concepts of therapy. Ann Intern Med (1978) 4.15
Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team. N Engl J Med (1999) 4.12
Factors in the prognosis of meningococcal infection. Review of 63 cases with emphasis on recognition and management of the severely ill patient. J Pediatr (1966) 3.52
Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects. N Engl J Med (1983) 2.91
Rapid serologic testing with immune-complex-dissociated HIV p24 antigen for early detection of HIV infection in neonates. Southern California Pediatric AIDS Consortium. N Engl J Med (1993) 2.58
Elevated cord macroglobulins in the diagnosis of intrauterine infections. N Engl J Med (1966) 2.50
Passive immunity in prevention and treatment of infectious diseases. Clin Microbiol Rev (2000) 2.38
Proposed definitions for in utero versus intrapartum transmission of HIV-1. N Engl J Med (1992) 2.33
Epidemic measles in young adults. Clinical, epidemiologic, and serologic studies. Ann Intern Med (1979) 2.29
Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery. JAMA (1994) 2.14
Human immunodeficiency virus type 1 genetic evolution in children with different rates of development of disease. J Virol (1997) 2.11
Serologic analysis of first-episode nonprimary genital herpes simplex virus infection. Presence of type 2 antibody in acute serum samples. Am J Med (1984) 2.05
Treatment of cytomegalovirus retinopathy with ganciclovir. Ophthalmology (1987) 2.03
A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group. N Engl J Med (1994) 1.97
Therapy of herpes zoster with oral acyclovir. Am J Med (1988) 1.89
Immunologic responses in malnourished children. Am J Clin Nutr (1975) 1.78
Intraepithelial eosinophils: a new diagnostic criterion for reflux esophagitis. Gastroenterology (1982) 1.73
Decreased mononuclear and polymorphonuclear chemotaxis in human newborns, infants, and young children. Pediatrics (1977) 1.70
Increased prevalence of W27 in juvenile rheumatoid arthritis. N Engl J Med (1974) 1.58
Primary HIV infection of infants: the effects of somatic growth on lymphocyte and virus dynamics. Clin Immunol (1999) 1.57
Autoimmune enteropathy and nephropathy with circulating anti-epithelial cell antibodies. J Pediatr (1991) 1.55
Early treatment with acyclovir for varicella pneumonia in otherwise healthy adults: retrospective controlled study and review. Rev Infect Dis (1990) 1.54
Optimization of specimen-handling procedures for accurate quantitation of levels of human immunodeficiency virus RNA in plasma by reverse transcriptase PCR. J Clin Microbiol (1998) 1.53
The Wiskott-Aldrich syndrome. Results of transfer factor therapy. J Clin Invest (1972) 1.50
Decreased rosette-forming lymphocytes in malnutrition and intrauterine growth retardation. J Pediatr (1974) 1.48
Ringed esophagus: an association with esophagitis. Am J Gastroenterol (1992) 1.47
The management of pregnancies complicated by genital infections with herpes simplex virus. Clin Infect Dis (1992) 1.45
Decreased bactericidal activity of leukocytes of stressed newborn infants. Pediatrics (1975) 1.45
A position paper of the North American Society for Pediatric Gastroenterology and Nutrition. Pediatric gastroenterology Workforce Survey and future supply and demand. J Pediatr Gastroenterol Nutr (1998) 1.45
Standard and special human immune serum globulins as therapeutic agents. Pediatrics (1979) 1.44
Unrelated umbilical cord stem cell transplantation for X-linked immunodeficiencies. J Pediatr (2001) 1.41
Impaired production of gamma-interferon by newborn cells in vitro is due to a functionally immature macrophage. J Immunol (1985) 1.40
Impaired opsonic activity but normal phagocytosis in low-birth-weight infants. N Engl J Med (1969) 1.39
Clinical and immunologic features of dysgammaglobulinemia type I. Report of a case diagnosed in the first year of life. Am J Med (1966) 1.39
Perinatal transmission of major, minor, and multiple maternal human immunodeficiency virus type 1 variants in utero and intrapartum. J Virol (2001) 1.37
Early prognostic indicators in primary perinatal human immunodeficiency virus type 1 infection: importance of viral RNA and the timing of transmission on long-term outcome. J Infect Dis (1998) 1.37
Split products of fibrin in human renal disease. Am J Med (1969) 1.36
The syndrome of cellular immunodeficiency with immunoglobulins. J Pediatr (1974) 1.36
Elevated serum IgA globulin in anaphylactoid purpura. Pediatrics (1971) 1.35
Latex allergy in hospital employees. Ann Allergy (1994) 1.33
The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082). Zidovudine Collaborative Working Group. Am J Obstet Gynecol (1993) 1.31
Aspirin intolerance in chronic childhood asthma: Detected by oral challenge. Pediatrics (1975) 1.29
Combined antiviral effects of interferon, adenine, arabinoside, hypoxanthine arabinoside, and adenine arabinoside-5'-monophosphate in human fibroblast cultures. Antimicrob Agents Chemother (1977) 1.27
Defective T cell function in atopic dermatitis. J Allergy Clin Immunol (1976) 1.26
Glycogen storage disease type III (glycogen debranching enzyme deficiency): correlation of biochemical defects with myopathy and cardiomyopathy. Ann Intern Med (1992) 1.25
In vitro susceptibility of varicella zoster virus to adenine arabinoside and hypoxanthine arabinoside. Antimicrob Agents Chemother (1976) 1.24
Immune globulin levels in colostrum and breast milk, and serum from formula- and breast-fed newborns. Proc Soc Exp Biol Med (1967) 1.23
Effect of oral acyclovir on pain resolution in herpes zoster: a reanalysis. J Med Virol (1993) 1.22
Growth and body composition in children infected with the human immunodeficiency virus-1. Am J Clin Nutr (1993) 1.22
Coexistent respiratory allergy and cystic fibrosis. Am J Dis Child (1974) 1.21
Plasma infusions in immunologic deficiency states: metabolic and therapeutic studies. Blood (1966) 1.20
Double-blind controlled study of central nervous system side effects of amantadine, rimantadine, and chlorpheniramine. Antimicrob Agents Chemother (1982) 1.20
The alpha 1-antitrypsin gene is expressed in a human intestinal epithelial cell line. J Biol Chem (1989) 1.18
Use of intravenous gamma-globulin in antibody immunodeficiency: results of a multicenter controlled trial. Clin Immunol Immunopathol (1982) 1.14
Esophageal adenocarcinoma 20 years after esophageal atresia repair. J Pediatr Surg (1989) 1.14
Corticosteroids in treatment of obstructive lesions of chronic granulomatous disease. J Pediatr (1987) 1.14
A prospective double-blind study of side effects associated with the administration of amantadine for influenza A virus prophylaxis. J Infect Dis (1980) 1.13
The effects of acyclovir on antibody response to herpes simplex virus in primary genital herpetic infections. J Infect Dis (1984) 1.13
The DiGeorge syndrome and the fetal alcohol syndrome. Am J Dis Child (1982) 1.12
Identification of human immunodeficiency virus-1 RNA and DNA in the heart of a child with cardiovascular abnormalities and congenital acquired immune deficiency syndrome. Am J Cardiol (1990) 1.12
NASPGN guidelines for training in pediatric gastroenterology. NASPGN Executive Council, NASPGN Training and Education Committee. J Pediatr Gastroenterol Nutr (1999) 1.12
Characterization of spontaneous colitis in cotton-top tamarins (Saguinus oedipus) and its response to sulfasalazine. Gastroenterology (1985) 1.11
Surgical treatment of pancreas divisum causing pancreatitis in children. J Pediatr Surg (1989) 1.11
Rapid increases in load of human immunodeficiency virus correlate with early disease progression and loss of CD4 cells in vertically infected infants. J Infect Dis (1994) 1.10
Treatment of cytomegalovirus pneumonia after marrow transplant with combined vidarabine and human leukocyte interferon. J Infect Dis (1982) 1.09
Effect of protease inhibitors combined with standard antiretroviral therapy on linear growth and weight gain in human immunodeficiency virus type 1-infected children. Pediatr Infect Dis J (2001) 1.09
UCLA conference. Interferon: immunobiology and clinical significance. Ann Intern Med (1982) 1.08
The chondro-osseous dysplasia of adenosine deaminase deficiency with severe combined immunodeficiency. J Pediatr (1976) 1.08
IgG antibody response to polyethylene glycol-modified adenosine deaminase in patients with adenosine deaminase deficiency. J Clin Invest (1992) 1.08
Fetal defense mechanisms. Am J Dis Child (1975) 1.07
Quantitative analysis of mononuclear cells expressing human immunodeficiency virus type 1 RNA in esophageal mucosa. J Exp Med (1994) 1.07
Immune globulin levels in the sudden death syndrome. Pediatrics (1968) 1.06
T cell activation in pediatric AIDS pathogenesis: three-color immunophenotyping. Clin Immunol Immunopathol (1994) 1.05
Pharmacokinetics of acyclovir in the term human pregnancy and neonate. Am J Obstet Gynecol (1991) 1.05
Infectious complications of the primary immunodeficiencies. Clin Immunol Immunopathol (1986) 1.04
Increased susceptibility of neonatal monocyte/macrophages to HIV-1 infection. AIDS Res Hum Retroviruses (1993) 1.04
Pediatric predictive index for hospitalization in acute asthma. Ann Emerg Med (1987) 1.04
In vitro analysis of humoral immunity in antibody deficiency with normal immunoglobulins. Clin Immunol Immunopathol (1980) 1.03
Splenic hemangioma with thrombocytopenia and afibrinogenemia. J Pediatr (1968) 1.03
Influence of gestational age on serum levels of alpha-1 fetoprotein, IgG globulin, and albumin in newborn infants. J Pediatr (1973) 1.02
Steroid effects on the course of abdominal pain in children with Henoch-Schonlein purpura. Pediatrics (1987) 1.02
Colobronchial fistula as a late complication of coloesophageal interposition. Gastroenterology (1984) 1.02
Middle ear ciliary defect in Kartagener's syndrome. Pediatrics (1978) 1.02
Miconazole in the treatment of chronic mucocutaneous candidiasis: a preliminary report. J Pediatr (1977) 1.02
Clinical reactivation of herpes simplex virus type 2 infection in seropositive pregnant women with no history of genital herpes. Ann Intern Med (1993) 1.02
Diagnosis of HIV infection in children. Pediatr Clin North Am (2000) 1.02
Cellular (T cell) immunity in the human newborn. Pediatrics (1979) 1.01